Viewing Study NCT01927718

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-02-28 @ 9:10 PM
Study NCT ID: NCT01927718
Status: TERMINATED
Last Update Posted: 2019-04-29
First Post: 2013-08-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Blood And Marrow Transplantation View
None Myeloma View
None Multiple myeloma View
None MM View
None Autologous stem cell transplantation View
None ASCT View
None Thalidomide View
None Thalomid View
None Lenalidomide View
None CC-5013 View
None Revlimid View
None Questionnaires View
None Surveys View